Which of the following is NOT part of the Endogenous lipid metabolism pathway?
IDL
VLDL
Liver
Chylomicrons
At what age should LOW risk males and females begin screening for CHD, respectively?
35, 45
45, 35
25, 35
35, 25
Which of the following is a modifiable risk factor for CHD?
Peripheral artery disease
Carotid Artery Disease
HDL < 40
CKD
Which Rx can contribute to Hypertriglyceridemia?
Estrogen
Beta Blockers
HCTZ
All of these
A patient has a lipid profile as follows:
Cholesterol 187 Triglycerides 197 HDL 50mg/dl LDL 139
What can be concluded about this patient?
Her HDL is High Risk
Her Cholesterol level is Borderline
Her LDL is Borderline
Her triglyceride level is Desirable
A patient has a lipid profile completed and you notice that his TG value is 1892 mg/dL. Classically, you might expect what findings upon physical examination?
Eruptive xanthoma and lipemia retinalis
Eruptive xanthomas only
Lipemia retinalis only
Tuberous Xanthomas only
Which of the following is true regarding Hyperlipidemia Rx?
Fibric acids are most useful for lowering triglycerides
Resins are absolutely contraindicated in patients with TGs > 200 mg/dL
Nicotinic Acid, not Fibric Acid, is effective at raising HDL
Ezetimibe should never be combined with statins
Your patient has been taking statins and bile acid sequestrants for 6 months to lower his cholesterol. He comes back to your office and reports muscle pain all over his body and tells you his urine has a dark color. What is your next step?
Lower the statins, check his CK
Stop the statins and check his CK
Stop both Rx, check the CK
Add NSAIDS to regimen, check CK
Who would not stand to benefit from statins?
A 76yo diabetic with LDL 69mg/dL, no clinical ascvd.
Nondiabetic, no ASCVD with LDL 190mg/dL
A pt with stable angina
A nondiabetic without ASCVD with a 10-year ASCVD risk of 7.5%
You conclude a patient would benefit from Rx to control her lipid profile. Her hyperglycemia is a relative contraindication to what LDL-lowering medication?
Fibric Acid
Statins
Resins
Nicotinic acid
